Evidence map›Paper›PMID 42089362›Full record

ArticleThe Journal of infectious diseases2026

Enterotoxigenic Bacteroides fragilis Induces Host Genotype-Specific Colonic Epithelial and Immune Responses in Mice.

Taylor Southward, Yongbao Zhuang, Ada Tam, Hana Minsky, Jacqueline Ferri, John Michel, Shaoguang Wu, Xinqun Wu, Tatianna Larman, Franck Housseau and 3 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Taylor SouthwardDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yongbao ZhuangDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5171-3949
Ada TamDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hana MinskyDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-8038-4646
Jacqueline FerriDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John MichelDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shaoguang WuDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Xinqun WuDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Tatianna LarmanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-4629-6516
Franck HousseauDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
James R WhiteResphera Biosciences, Baltimore, Maryland, USA.
Cynthia L SearsDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jessica QueenDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-4924-6621

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI ALAN KEITH MEEKER · 1985 to 2026
$208.6M
Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI THOMPSON, ELIZABETH D · 1993 to 2022
$54.6M
Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Bloomberg PhilanthropiesBurroughs Wellcome Fund Career Award for Medical Scientists 1022128Cancer Grand Challenges OPTIMISTICCCancer Research UKEmerald Foundation, Inc.Johns Hopkins School of Medicine Physician Scientist Training ProgramJohns Hopkins UniversityNCI NIH HHS P30 CA006973NCI NIH HHS P50 CA062924NCI NIH HHS P50CA062924NIGMS NIH HHS 3-T32-GM136577NIGMS NIH HHS T32 GM136577NIHNIH HHSPearl M. Stetler Research FundVivien Thomas Scholars Initiative
6 · The paper itself

Abstract

backgroundColorectal cancer pathogenesis involves complex interactions between multiple risk factors including somatic mutations and microbial dysbiosis. A number of individual microbiota members have been implicated in colorectal cancer, including enterotoxigenic strains of Bacteroides fragilis (ETBF). Enterotoxigenic Bacteroides fragilis promotes inflammation in mouse models, which has been mechanistically linked to colon tumorigenesis. We hypothesized that ETBF would promote distinct patterns of colonic damage and inflammation in mice expressing different oncogenic mutations.

methodsMice expressing mutations in the Apc tumor suppressor gene or the BRAF or Kras oncogenes were colonized with ETBF to induce acute colitis. Seven days after colonization, tissues and stools were collected to assess for colonization, epithelial damage, and local and systemic immune responses.

resultsDespite uniform colonization of ETBF across all genotypes and some common features of colitis across groups, Apc, BRAF, and Kras mutations were associated with distinct patterns of colonic epithelial cell injury and goblet cell loss in response to ETBF. RNA sequencing analysis revealed varied transcriptional profiles based on mouse genotype and colon region. Flow cytometry of intra-epithelial leukocytes revealed differential recruitment of myeloid cells based on oncogenic mutation. In particular, mutant BRAF expression was uniquely associated with more systemic inflammation, resistance to goblet cell loss, an interferon gamma gene signature, and recruitment of a macrophage-like polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) population in the midproximal colon.

conclusionsEnterotoxigenic Bacteroides fragilis promotes acute colitis in mice expressing different oncogenic mutations, but with distinct patterns of colonic epithelial cell damage and inflammation dependent on host oncogene context.

Indexed as

Bacteroides fragilisBacteroides InfectionsColitisColonIntestinal MucosaAnimalsColorectal NeoplasmsDisease Models, AnimalEpithelial CellsGenotypeMiceMice, Inbred C57BLMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)bacteroidescolitiscolorectal cancermicrobiomeoncogene

Identifiers

PMID42089362
PMCPMC13431769

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.